BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21722313)

  • 1. PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL.
    Cubedo E; Maurin M; Jiang X; Lossos IS; Wright KL
    FEBS J; 2011 Sep; 278(17):3065-75. PubMed ID: 21722313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components.
    Younes SF; Beck AH; Lossos IS; Levy R; Warnke RA; Natkunam Y
    Am J Surg Pathol; 2010 Sep; 34(9):1266-76. PubMed ID: 20697248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.
    Younes SF; Beck AH; Ohgami RS; Lossos IS; Levy R; Warnke RA; Natkunam Y
    Am J Clin Pathol; 2011 May; 135(5):697-708. PubMed ID: 21502424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of GCET1, HGAL (GCET2), and LMO2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell Lymphoma.
    Berker N; Yeğen G; Özlük Y; Doğan Ö
    Turk J Haematol; 2023 Aug; 40(3):162-173. PubMed ID: 37519110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.
    Natkunam Y; Hsi ED; Aoun P; Zhao S; Elson P; Pohlman B; Naushad H; Bast M; Levy R; Lossos IS
    Blood; 2007 Jan; 109(1):298-305. PubMed ID: 16954503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
    Moore EM; Swerdlow SH; Gibson SE
    Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
    Natkunam Y; Zhao S; Mason DY; Chen J; Taidi B; Jones M; Hammer AS; Hamilton Dutoit S; Lossos IS; Levy R
    Blood; 2007 Feb; 109(4):1636-42. PubMed ID: 17038524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms.
    Menter T; Gasser A; Juskevicius D; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):491-8. PubMed ID: 25203428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract.
    Chapman-Fredricks J; Younes SF; Fan YS; Sandoval-Sus JD; Natkunam Y; Lossos IS
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):200-4. PubMed ID: 22914613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.
    Natkunam Y; Lossos IS; Taidi B; Zhao S; Lu X; Ding F; Hammer AS; Marafioti T; Byrne GE; Levy S; Warnke RA; Levy R
    Blood; 2005 May; 105(10):3979-86. PubMed ID: 15677569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
    Cubedo E; Gentles AJ; Huang C; Natkunam Y; Bhatt S; Lu X; Jiang X; Romero-Camarero I; Freud A; Zhao S; Bacchi CE; Martínez-Climent JA; Sánchez-García I; Melnick A; Lossos IS
    Blood; 2012 Jun; 119(23):5478-91. PubMed ID: 22517897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.
    Pasqualucci L; Compagno M; Houldsworth J; Monti S; Grunn A; Nandula SV; Aster JC; Murty VV; Shipp MA; Dalla-Favera R
    J Exp Med; 2006 Feb; 203(2):311-7. PubMed ID: 16492805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of HGAL and LMO2 in follicular lymphoma].
    Zhang F; Luo D; Luo X; Chen Y; Xu J; Chen J; Zhuang H; Liu Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Feb; 45(2):83-5. PubMed ID: 26879427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.
    Malumbres R; Sarosiek KA; Cubedo E; Ruiz JW; Jiang X; Gascoyne RD; Tibshirani R; Lossos IS
    Blood; 2009 Apr; 113(16):3754-64. PubMed ID: 19047678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-155 regulates HGAL expression and increases lymphoma cell motility.
    Dagan LN; Jiang X; Bhatt S; Cubedo E; Rajewsky K; Lossos IS
    Blood; 2012 Jan; 119(2):513-20. PubMed ID: 22096245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.
    Lossos IS; Alizadeh AA; Rajapaksa R; Tibshirani R; Levy R
    Blood; 2003 Jan; 101(2):433-40. PubMed ID: 12509382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
    Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
    Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.
    Boi M; Zucca E; Inghirami G; Bertoni F
    Leuk Lymphoma; 2015 May; 56(5):1223-8. PubMed ID: 25115512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
    Oram SH; Thoms JA; Pridans C; Janes ME; Kinston SJ; Anand S; Landry JR; Lock RB; Jayaraman PS; Huntly BJ; Pimanda JE; Göttgens B
    Oncogene; 2010 Oct; 29(43):5796-808. PubMed ID: 20676125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.